Unofficial; not affiliated with the European Commission. Source: European Commission, EU Funding & Tenders Portal. Reused under the Commission's reuse policy (Decision 2011/833/EU, CC BY 4.0); we reorganise the facts and add counts.
Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications (HORIZON-HLTH-2027-01-CARE-02) is a forthcoming funding topic under Horizon Europe with a stated budget of €38 million. The next deadline is , 123 days away as of . It is planned to open on .
In our daily copy of EU Funding & Tenders Portal data (), 9 other topics in call HORIZON-HLTH-2027-01 are listed; Horizon Europe has 376 open or forthcoming calls here; the median stated budget for Horizon Europe calls is €12 million; 41 Horizon Europe calls have a deadline in February 2027.
| Identifier | HORIZON-HLTH-2027-01-CARE-02 |
|---|---|
| Programme | Horizon Europe |
| Status | Forthcoming |
| Opening date | |
| Deadline | |
| Submission | Single-stage |
| Type of action | Horizon Europe Research and Innovation Actions |
| Budget | €38 million (2027 budget) |
| Expected number of grants | 4 |
| EU contribution per project | €8 million to €10 million |
| Call | HORIZON-HLTH-2027-01 — Cluster 1 - Health (Single stage - 2027/1) |
| Themes on this site | Health, Digital and data |
| Cross-cutting priorities (portal) | Societal Engagement, Social Innovation, Artificial Intelligence, Digital Agenda |
| Portal keywords | Biobanks, Clinical Pharmacology, Co-morbidity, Health data, Personalised services, Personalised treatment, Pharmacovigilance, Tertiary prevention, ADR, adverse drug reactions |
Read the official topic page on the EU Funding & Tenders Portal
Type of action
Research and innovation actions fund new knowledge or the feasibility of a new technology, product or service. They usually need a consortium of partners from several countries.
Deadline
Deadline as published: . Check the official page for the exact time and any changes; late submissions are not accepted.
Next steps
- Open the official topic page and read the conditions, the call document and the evaluation criteria.
- Create a free EU Login and register your organisation to get a PIC, if you do not have one.
- Find partners if the topic needs a consortium (the portal's partner search is free).
- Start a draft in the submission system from the topic page and submit before the deadline.
New to EU funding? Read how to apply for EU funding.
Related calls
- Addressing disabilities through the life course to support independent living and inclusion — HORIZON-HLTH-2027-01-STAYHLTH-01, next deadline
- Development of cell-free protein synthesis platforms for discovery and/or production of biologicals — HORIZON-HLTH-2027-01-IND-01, next deadline
- Development of innovative antimicrobials against pathogens resistant to antimicrobials — HORIZON-HLTH-2027-01-DISEASE-08, next deadline
- Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses — HORIZON-HLTH-2027-01-DISEASE-07, next deadline
- Development of monoclonal antibodies to prevent and treat infections from Flaviviruses — HORIZON-HLTH-2027-01-DISEASE-06, next deadline
- Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential — HORIZON-HLTH-2027-01-DISEASE-05, next deadline
- Biotechnology for Healthy Ageing — HORIZON-EIC-2026-PATHFINDERCHALLENGES-01-02, next deadline
- Development of innovative tools, processes, equipment and technologies through responses to disasters and emergencies for search and rescue in hazardous conditions — HORIZON-CL3-2026-01-DRS-03, next deadline
- Multi-hazard approach and cumulative / cascading impacts — HORIZON-CL3-2026-01-DRS-02, next deadline
- Open topic on driving innovation uptake of disaster risk solutions — HORIZON-CL3-2026-01-DRS-04, next deadline